← European Medicine Shortage Tracker · all medicines

Reboxetina shortage — availability across Europe

Reboxetina currently has availability issues reported in 1 European register: Italy.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Shortage ATC — · also listed as: REBOXETINA · data refreshed 7 August 2026

Key facts

As of 7 August 2026, Reboxetina has active availability issues in 1 of 10 tracked European registers.
Registers reporting issues: Italy.
Data source: 1 official medicines-agency register, refreshed daily.

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Reboxetina, covering 2 affected product presentations. Where agencies state a cause, commercial decisions or discontinuation lead with 2 of the 2 stated-cause reports. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇮🇹 Italy	Shortage EDRONAX + 1 more products EDRONAX	2026-07-31	—	Cessata commercializzazione definitiva Alternatives: AIFA: an alternative treatment is available (ask your doctor).	register ↗

New register reports per month

Full report history (2 register entries)

Every individual register entry for Reboxetina in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇮🇹 IT	EDRONAX	Shortage	2026-08-31	—	Cessata commercializzazione definitiva
🇮🇹 IT	EDRONAX	Shortage	2026-07-31	—	Cessata commercializzazione definitiva

Frequently asked

Is Reboxetina currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

Are there alternatives to Reboxetina?

2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Reboxetina availability data come from?

Directly from the official medicines-agency register that lists Reboxetina: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Reboxetina — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/reboxetina/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Reboxetina availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/reboxetina/">Reboxetina shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Reboxetina: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.